Massachusetts General Hospital successfully conducted the fourth pig kidney transplant in the U.S. on a 66-year-old patient, part of a new FDA-sanctioned clinical trial to tackle the organ shortage. This transplant highlights the growing use of genetically modified pig organs, as over 100,000 people await kidney transplants in the U.S. Despite previous complications, the latest recipient, Tim Andrews, recovered well. The trial, utilizing organs from eGenesis, aims to offer alternatives that reduce rejection risks, with expectations for future studies involving more patients seeking viable organ solutions.
Surgeons in Boston successfully transplanted a genetically modified pig kidney into a 66-year-old man with kidney failure, marking a significant advancement in organ transplantation.
The latest transplant is part of a new clinical trial authorized by the FDA, aimed at addressing the critical shortage of human donor organs.
Collection
[
|
...
]